Dashboard
Manage Tickers

SGHTSight Sciences, Inc.

Nasdaq sightsciences.com


$ 5.80 $ -0.14 (-2.35 %)    

Monday, 06-May-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 5.82
$ 6.00
$ 0.00 x 0
$ 0.00 x 0
$ 5.80 - $ 6.00
$ 1.04 - $ 10.97
95,425
na
288.01M
$ 2.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-reiterates-neutral-on-sight-sciences-raises-price-target-to-6
Piper Sandler Reiterates Neutral on Sight ...
05/03/2024 13:40:29

Piper Sandler analyst Matt O'Brien reiterates Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target fr...

needham-reiterates-hold-on-sight-sciences
Needham Reiterates Hold on Sight Sciences
05/03/2024 09:55:10

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.

sight-sciences-reaffirms-fy24-revenue-guidance-81m-85m-vs-8248m-est
Sight Sciences Reaffirms FY24 Revenue Guid...
05/02/2024 21:56:52

sight-sciences-q1-2024-gaap-eps-033-misses-030-estimate-sales-19265m-beat-18382m-estimate
Sight Sciences Q1 2024 GAAP EPS $(0.33) Mi...
05/02/2024 21:23:37

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0....

sight-sciences-announces-34m-patent-infringement-verdict-against-alcon-and-its-hydrus-microstent-for-microinvasive-glaucoma-surgery--monetary-damages-comprised-of-55m-in-lost-profits-and-285m-in-royalty-damages-for-sales-of-the-hydrus-microstent-for-the-period-from-its-commercial-launch-through-trial
Sight Sciences Announces $34M Patent Infri...
04/29/2024 12:06:24

sight-sciences-announces-the-publication-of-large-scale-real-world-migs-study-demonstrating-the-aqueous-outflow-restorative-procedure-with-omni-surgical-system-technology-is-effective-at-lowering-both-iop-and-iop-reducing-medications-at-2-years-in-patients-with-glaucoma
Sight Sciences Announces The Publication O...
04/10/2024 20:08:14

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused o...

needham-reiterates-hold-on-sight-sciences
Needham Reiterates Hold on Sight Sciences
04/10/2024 09:24:18

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.

sight-sciences-shares-are-trading-higher-after-the-company-announced-data-from-studies-of-two-of-its-glaucoma-and-dry-eye-technologies-will-be-presented-at-the-2024-american-society-of-cataract-and-refractive-surgery-annual-meeting
Sight Sciences shares are trading higher a...
04/03/2024 11:26:08

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

sight-sciences-announces-the-results-of-the-3-year-prospective-gemini-trial-and-the-cross-over-phase-of-the-sahara-rct-at-the-2024-american-society-of-cataract-and-refractive-surgery-annual-meeting
Sight Sciences Announces The Results Of Th...
04/02/2024 20:13:05

Clinical results demonstrate long-term efficacy of the OMNI® Surgical System for primary open-angle glaucoma and support use of...

stifel-maintains-buy-on-sight-sciences-raises-price-target-to-7
Stifel Maintains Buy on Sight Sciences, Ra...
03/08/2024 15:47:44

Stifel analyst Thomas Stephan maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $6 to $7.

sight-sciences-projects-2024-revenue-81m-85m-vs-8241m-est
Sight Sciences Projects 2024 Revenue $81M-...
03/07/2024 22:11:09

sight-sciences-q4-earnings-insights
Sight Sciences: Q4 Earnings Insights
03/07/2024 21:40:13

sight-sciences-q4-2023-gaap-eps-0220-beats-0340-estimate-sales-18800m-miss-18926m-estimate
Sight Sciences Q4 2023 GAAP EPS $(0.220) B...
03/07/2024 21:25:28

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.220) per share which beat the analyst consensus estimate of $(0.3...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

sight-sciencess-earnings-a-preview
Sight Sciences's Earnings: A Preview
03/06/2024 15:02:33

sight-sciences-announces-european-launch-of-the-ergo-series-of-the-omni-surgical-system-at-the-escrs-winter-meeting
Sight Sciences Announces European Launch O...
02/14/2024 21:37:51

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused o...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/24/2024 17:31:02

sight-sciences-expects-fy23-total-revenue-of-809m-811m-est-8042m-up-14-yy-at-estimated-midpoint
Sight Sciences Expects FY23 Total Revenue ...
01/08/2024 21:12:26

sight-sciences-expects-q4-total-revenue-of-186m-188m-est-1818m-a-decrease-of-9-yy-at-estimated-midpoint
Sight Sciences Expects Q4 Total Revenue Of...
01/08/2024 21:09:46

The Company's cash and cash equivalents as of December 31, 2023, was approximately $138 million, compared to $144.5 million...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION